{"id":5684,"date":"2020-04-06T10:25:36","date_gmt":"2020-04-06T17:25:36","guid":{"rendered":"http:\/\/www.acsr1.com\/?p=5684"},"modified":"2026-07-30T11:53:19","modified_gmt":"2026-07-30T18:53:19","slug":"notice-of-special-interest-covid_19","status":"publish","type":"post","link":"https:\/\/acsr1.com\/?p=5684","title":{"rendered":"Notice of Special Interest: Funding for Research on SARS-CoV-2 and COVID-19"},"content":{"rendered":"
\n
\n\t\t\"Covid\n\t<\/div>\n\n<\/div><\/div>

Notice of Special Interest: Funding for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)<\/h3>\n
\n\t

Notice Number:<\/span>\u00a0NOT-AI-20-034<\/span><\/p>\n

Key Dates<\/span>
Release Date:<\/strong>\u00a0March 25, 2020
First Available Due Date:<\/strong>\u00a0March 25, 2020
Expiration Date:<\/strong>\u00a0March 25, 2021<\/p>\n

Related Announcements<\/span>
NOT-AI-20-040<\/a>
PA-20-135<\/a>; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)<\/p>\n

Issued by<\/span>
National Institute of Allergy and Infectious Diseases (NIAID<\/a>)<\/p>\n

Purpose<\/p>\n

\n

NIAID is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2\/COVID-19.<\/p>\n<\/div>\n

Read more<\/strong>...<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Notice Number:\u00a0NOT-AI-20-034 Key DatesRelease Date:\u00a0March 25, 2020First Available Due Date:\u00a0March 25, 2020Expiration Date:\u00a0March 25, 2021 Related AnnouncementsNOT-AI-20-040PA-20-135; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) …<\/p>\n","protected":false},"author":2,"featured_media":5710,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false},"categories":[23,34],"tags":[71,70,72,74],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t